Insights

Advanced Diagnostic Technology Hememics Biotechnologies offers portable, lab-quality testing devices that utilize graphene-based sensors, providing rapid molecular, antigen, and antibody detection in varied settings such as farms, emergency rooms, and battlefield environments. This positions them as a prime solution for organizations requiring swift, on-site diagnostic capabilities.

Growing Manufacturing Capacity The company has successfully manufactured over 100,000 graphene biosensors in collaboration with General Graphene Corp., indicating a scalable production process that can meet increasing demand from potential clients in healthcare, agriculture, and security sectors.

Recent Capital Injections With a recent $2 million Seed 2 financing round supported by TEDCO and other investors, Hememics has strengthened its financial foundation to expand sales efforts, develop new market segments, and further enhance its sensor technology.

Strategic Partnerships Partnerships with health authorities like BARDA and collaborations with graphene manufacturers showcase Hememics’ commitment to innovation andpotential for expanding into government and large enterprise markets that prioritize rapid diagnostics and pathogen detection.

Market Expansion Potential Hememics's focus on COVID-19 diagnostics and rapid testing solutions aligns with ongoing global health initiatives and market trends toward decentralized testing, offering opportunities for sales in healthcare institutions, diagnostic labs, and emergency response agencies.

Hememics Biotechnologies, Inc. Tech Stack

Hememics Biotechnologies, Inc. uses 8 technology products and services including Open Graph, Twemoji, Sirvoy, and more. Explore Hememics Biotechnologies, Inc.'s tech stack below.

  • Open Graph
    Content Management System
  • Twemoji
    Font Scripts
  • Sirvoy
    Hotel Management
  • jQuery Migrate
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • HTTP/3
    Web & Portal Technology
  • GoDaddy
    Web Hosting
  • Apache
    Web Servers

Media & News

Hememics Biotechnologies, Inc.'s Email Address Formats

Hememics Biotechnologies, Inc. uses at least 1 format(s):
Hememics Biotechnologies, Inc. Email FormatsExamplePercentage
FLast@hememics.comJDoe@hememics.com
88%
First@hememics.comJohn@hememics.com
12%

Frequently Asked Questions

Where is Hememics Biotechnologies, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc.'s main headquarters is located at 401 Professional Drive 220 Gaithersburg, Maryland United States. The company has employees across 2 continents, including North AmericaEurope.

What is Hememics Biotechnologies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc.'s official website is hememics.com and has social profiles on LinkedInCrunchbase.

What is Hememics Biotechnologies, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Hememics Biotechnologies, Inc. have currently?

Minus sign iconPlus sign icon
As of June 2026, Hememics Biotechnologies, Inc. has approximately 11 employees across 2 continents, including North AmericaEurope. Key team members include Ceo: J. L. W.Chief Financial Officer: R. L.Chief Investment Officer: T. D.. Explore Hememics Biotechnologies, Inc.'s employee directory with LeadIQ.

What industry does Hememics Biotechnologies, Inc. belong to?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc. operates in the Biotechnology Research industry.

What technology does Hememics Biotechnologies, Inc. use?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc.'s tech stack includes Open GraphTwemojiSirvoyjQuery MigrateModernizrHTTP/3GoDaddyApache.

What is Hememics Biotechnologies, Inc.'s email format?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc.'s email format typically follows the pattern of FLast@hememics.com. Find more Hememics Biotechnologies, Inc. email formats with LeadIQ.

How much funding has Hememics Biotechnologies, Inc. raised to date?

Minus sign iconPlus sign icon
As of June 2026, Hememics Biotechnologies, Inc. has raised $250K in funding. The last funding round occurred on Mar 19, 2025 for $250K.

When was Hememics Biotechnologies, Inc. founded?

Minus sign iconPlus sign icon
Hememics Biotechnologies, Inc. was founded in 2007.
Hememics Biotechnologies, Inc. logo

Hememics Biotechnologies, Inc.

Biotechnology ResearchMaryland, United States11-50 Employees

Hememics Biotechnologies, Inc. is a biotechnology research company based in Gaithersburg, Maryland. It develops portable diagnostic platforms that combine graphene-based sensors with disposable biochips to deliver lab-quality results in settings such as farms, emergency rooms, and field environments, with results available in minutes. The company targets users who require rapid, on-site testing and decision-making capabilities, offering a handheld reader and programmable sensors that can detect molecular, antigen, and antibody targets, thereby simplifying testing workflows. Hememics positions itself within the biotechnology and rapid diagnostics space by providing a rugged, low-cost, end-to-end testing solution that brings laboratory-level capabilities to non-traditional lab environments. In recent developments, the company announced a partnership with General Graphene Corp., reflecting ongoing collaboration to manufacture graphene biosensors. Established in the United States, Hememics emphasizes its focus on rapid diagnostic tools and point-of-care applications through its technology platform. }

Section iconCompany Overview

Headquarters
401 Professional Drive 220 Gaithersburg, Maryland United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
11-50

Section iconFunding & Financials

  • $250K

    Hememics Biotechnologies, Inc. has raised a total of $250K of funding over 4 rounds. Their latest funding round was raised on Mar 19, 2025 in the amount of $250K.

  • $1M$10M

    Hememics Biotechnologies, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $250K

    Hememics Biotechnologies, Inc. has raised a total of $250K of funding over 4 rounds. Their latest funding round was raised on Mar 19, 2025 in the amount of $250K.

  • $1M$10M

    Hememics Biotechnologies, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.